Skip to main content
. 2022 Aug 3;11(8):875. doi: 10.3390/pathogens11080875

Figure 6.

Figure 6

M-T5—an activator of the Akt serine/threonine kinase. The MYXV M-T5 protein binds the cellular Akt serine/threonine kinase when phosphorylated on threonine (T) 308. This promotes the further phosphorylation of Akt on serine (S) 473 to fully activate the kinase. The activation of Akt is proposed to lead to the phosphorylation of the cyclin-dependent kinase inhibitor p27kip1 on T187. The phosphorylation of p27kip1 on this site is then recognized by the cellular SCFskp2 E3 Ub ligase, resulting in the Ub-mediated degradation of p27kip1. This overcomes the cell cycle block and allows MYXV infection to proceed.